For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Capsaicin - Pain (Neuropathic)
PAD Profile : Capsaicin - Pain (Neuropathic) Important
Traffic Light Status
Status 1 of 2.
- Cream
Status 2 of 2.
- Patches
Guidelines
No guidelines returned.
Other Drugs
- Duloxetine hydrochloride
- Amitriptyline hydrochloride
- Gabapentin
- Pregabalin
- Nortriptyline
- Imipramine hydrochloride
- Dosulepin hydrochloride
- Tramadol hydrochloride
Other Indications
Additional Documents
Committee Recommendations
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) approves the use of capsaicin patches for the treatment of neuropathic pain when prescribed by specialist pain teams within a secondary care setting only.
The APC recommend a RED traffic light status for the use of capsaicin patches for this indication only.
Primary care prescribers should be aware that their patient is receiving this medicine and ensure that this is recorded on the patient’s medication screen as a hospital-only drug in line with guidance on the PAD. This will also alert the prescriber to potential side effects and interactions with other medicines prescribed in primary care. It will also ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.”
Capsaicin cream 0.075% (Axsain) is recommended at step 1 of the neuropathic pain guidelines for patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine).
See neuropathic pain guidelines for more information.
NOTE - capsaicin patches (Qutenza) are not recommended and have a non-formulary traffic light status.